speb/financial-data huggingface dataset:
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1306000.00
AYMSYNTEX.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 168908000.00
AYMSYNTEX.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2566927000.00
AYMSYNTEX.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 69400000.00
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 107863000.00
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Special Income Charges: -21159000.00
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 116206000.00
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -20767000.00
AYMSYNTEX.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -20767000.00
AYMSYNTEX.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 50290000.00
AYMSYNTEX.NS balance_sheet (annual, 2022-03-31) — Work In Process: 179573000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — +Operating Expense: 4334469000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — +Total Revenue: 14263038000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1925187000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1040475000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2655115000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 745321000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -6253000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Amortization: 1249000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 570000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 10636000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 50268023.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Basic EPS: 1.42
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 38507000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 974220000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -779513000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 77402000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 503533000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 90880000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 222101000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 90880000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -111162000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 160185000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 1344000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Payable: 106206000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 68253000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 209575000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 52387000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Common Stock: 503533000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 4202481000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 1997000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 356157000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 9529944000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4103674000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 60284000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1163796000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1224080000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 3369321000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Depreciation: 565187000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 565187000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 565187000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 563938000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 50769876.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Diluted EPS: 1.41
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — EBIT: 359347000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — EBITDA: 924534000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — End Cash Position: 90880000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -389584000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 754292000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 401688000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 11065000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 118749000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1933000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1046728000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 7489527000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Gross Profit: 4733094000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Interest Expense: 253044000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 253044000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Interest Income: 22140000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 22140000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -356596000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 7138000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Inventory: 1994026000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 6882514000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -739230000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 10636000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 1997000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 165204000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 17118000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1516237000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1533355000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 5973770000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 1997000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2589153000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -466000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 71620000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 106357000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 71620000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Interest Income: -337802000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 29869000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -93457000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 76884000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -337802000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 120000000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -9000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Net PPE: 4834412000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -776228000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -170341000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4200548000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 199582000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 74227000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 29680000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 934456000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Normalized Income: 78304793.84
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1181201000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Operating Income: 398625000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Operating Revenue: 14263038000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 50353314.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -14000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 826465000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 47000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 30389000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 1933000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 351603000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 56900000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 19470000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 2863905000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Payable: 115028000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Properties: 20176000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 143663000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 131221000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Other Special Charges: 9922000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Payables: 2040547000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 33681000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 702839000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Pretax Income: 106303000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -779513000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1003376000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9529944000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 565187000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1800000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1800000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 131221000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2646039000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 3285000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 118749000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Share Issued: 50353314.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Special Income Charges: -9922000.00
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 21638000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 4202481000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4200548000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -3237206.16
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Tax Provision: 34683000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.33
AYMSYNTEX.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -83738000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Assets: 9203612000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 5718718000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2757435000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 4202481000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Total Expenses: 13864413000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 5001131000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 5099938000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1631810000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 106898000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 332000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -9922000.00
AYMSYNTEX.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -9922000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 24228000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Work In Process: 236358000.00
AYMSYNTEX.NS balance_sheet (annual, 2023-03-31) — Working Capital: 734353000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4436394000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — +Total Revenue: 13146706000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2379270000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1228346000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -3141117000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 758062000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -14479000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Amortization: 509000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 4557000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 70600000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 50504488.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.40
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 90880000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1109858000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -575246000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 180369000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 506313000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 70524000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 70524000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 70524000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -152151000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -203435000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -6162000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Payable: 454706000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -453878000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -354965000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -20356000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Common Stock: 506313000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 4238194000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 2780000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 224159000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 8399983000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Current Assets: 4907038000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 57694000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1904083000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1961777000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 4653484000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Depreciation: 579146000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 579146000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 579146000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 578637000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 50797902.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.40
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — EBIT: 316105000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — EBITDA: 895251000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — End Cash Position: 70524000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -102636000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 710086000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 61169000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -20780000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 141461000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1424000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1242825000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 8165091000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Gross Profit: 4746723000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Interest Expense: 302932000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 302932000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Interest Income: 18088000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 18088000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -418874000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 9505000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Inventory: 2146177000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 7298076000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -554135000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 70600000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 2780000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 161541000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 122675000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 1155799000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1278474000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 6649039000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 2780000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Net Debt: 2989358000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -377000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 20399000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 13173000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 20399000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Interest Income: -402164000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -50946000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 379850000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 136506000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -402164000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Net PPE: 5023974000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -512694000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 243344000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 4236770000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 209204000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 77340000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 17643000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 816969000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Normalized Income: -34398400.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 636415000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Operating Income: 310329000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Operating Revenue: 13146706000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 50631264.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 1029700000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 61600000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 30505000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 1424000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 407829000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 36300000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 20338000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 2767573000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Payable: 209067000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Properties: 20494000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 466291000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 125293000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Other Special Charges: -78282000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Payables: 2588669000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 37999000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 865850000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Pretax Income: 13173000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -575246000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1250852000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 8399983000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 579146000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 3726000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 3726000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 125293000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2666115000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 62552000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 141461000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Share Issued: 50631264.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Special Income Charges: 78282000.00
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 12857000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 4238194000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 4236770000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 23484600.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Tax Provision: -7226000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
AYMSYNTEX.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -468000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Assets: 10247492000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 5393993000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Debt: 3240251000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 4238194000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Total Expenses: 12836377000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 6009298000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 5340454000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 1355814000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 117320000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 332000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 78282000.00
AYMSYNTEX.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 78282000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Work In Process: 185239000.00
AYMSYNTEX.NS balance_sheet (annual, 2024-03-31) — Working Capital: 253554000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2630300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 1372900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 70600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 150400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 507300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 35700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 423800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 507300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 4303900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 266500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 5133300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 40600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 2070200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2110800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 5077800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 5024500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 2470800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7315400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 70600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 109800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 941300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 1051100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2975800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 5024500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 4302700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 192300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 77700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 50731264.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 858700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 50400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 66500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 4758000000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 7100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 388100000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2639200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 80400000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 50731264.00
AYMSYNTEX.NS income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 4303900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 4302700000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 10510500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 5245200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 3161900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 4303900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 6206600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 5377200000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 1128800000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 8900000.00
AYMSYNTEX.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
AYMSYNTEX.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 55500000.00
AYMSYNTEX.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
AYMSYNTEX.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — +Operating Expense: 5861000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1480800000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — +Total Revenue: 14890000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3606200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2242494000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2242494000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1309308000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1309308000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3680642000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3680642000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2098982000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2098982000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -21810000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -21810000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Amortization: 457000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 457000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Assets Held For Sale Current: 1870000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 1870000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 57600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 57600000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 54600939.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 54594595.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Basic EPS: 2.13
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.37
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 70500000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1103500000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1103500000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -739300000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 167107000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 167107000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 584991000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 584991000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 181655000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 181655000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 181655000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 181655000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 181655000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 181655000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -359200000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: 304800000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 8200000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Payable: -134100000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 39600000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -129200000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 111200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Common Stock: 584991000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 584991000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5776345000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5776345000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 1419600000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 217984000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 217984000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 8467800000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2017200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5018659000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5018659000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 68757000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 68757000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1361941000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1361941000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1430698000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1430698000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 3870393000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3870393000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Depreciation: 620100000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 620100000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 620100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 158800000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 620100000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 158800000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 54858491.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 54594595.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Diluted EPS: 2.12
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.37
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — EBIT: 621300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — EBIT: 131200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — EBITDA: 1241400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — EBITDA: 290000000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — End Cash Position: 181700000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -281200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 993499000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 993499000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 341500000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 17100000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 186175000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 967000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 967000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1331118000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1331118000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 8719874000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 8719874000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Gross Profit: 6422200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1589000000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Interest Expense: 427700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 85600000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 427700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 85600000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Interest Income: 31979000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 31979000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -429100000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 15200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Inventory: 2505402000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2505402000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7627114000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7627114000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -688400000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 57600000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 57600000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 1419600000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 340805000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 340805000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 98350000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 98350000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 488828000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 488828000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 587178000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 587178000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 7035235000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 7035235000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 1419600000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1669114000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1669114000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -2600000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 20200000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 193600000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 20200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Interest Income: -427700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -85600000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 33300000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -1210400000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -780900000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -427700000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -85600000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5039232000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5039232000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -736900000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -429500000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 5775378000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5775378000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 166042000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 166042000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 75243000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 75243000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 43061000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 43061000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1241400000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 290000000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Normalized Income: 116300000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 20200000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1080800000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Operating Income: 561200000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Operating Income: 108200000.00
AYMSYNTEX.NS income_statement (annual, 2025-03-31) — Operating Revenue: 14890000000.00
AYMSYNTEX.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3606200000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 58499091.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 58499091.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 727300000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 727300000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 66900000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 66900000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 32079000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 32079000.00
AYMSYNTEX.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 967000.00
AYMSYNTEX.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 967000.00
AYMSYNTEX.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 410900000.00